Ebola -- Liberia
18 Nov 2015: Study finds that Ebola vaccine is safe and stimulates strong immune response
[According to a study published in the latest issue of the journal Lancet Infectious Disease, a clinical trial of a new Ebola vaccine (ChAd3-EBO-Z) has found that it is well tolerated and stimulates strong immune responses in adults in Mali, West Africa and in the US. Larger trials, sponsored by GSK Biologicals, have already started.
The full reference is: MD Tapia, SO Sow, KE Lyke. Use of
from HealthMap Global Disease Alerts http://bit.ly/1SSSSiD
via http://bit.ly/1SSSSiD
No comments:
Post a Comment